Clinical trial
A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With…
NCT00111644 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00111644 |
|---|---|
| Title | A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia |
| Official title | A Randomized, Double-blind Study of the Effect of Beta-lactam on Treatment Response in Patients Hospitalized With Bacterial Pneumonia |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pneumonia, Bacterial |
| Intervention type | Drug |
| Interventions | Ceftriaxone, beta-lactam |
| Enrollment | 302 |
| Start date | Mar 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | May 25, 2005 |
| Last update posted | Nov 2, 2016 |
| Countries | Argentina, Bulgaria, Chile, Croatia, Hungary, Latvia, Lithuania, Peru, Romania, Slovakia, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: